Nomura Holdings Inc. cut its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 72.8% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,117 shares of the semiconductor company's stock after selling 16,399 shares during the period. Nomura Holdings Inc.'s holdings in Synopsys were worth $2,623,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Williams Jones Wealth Management LLC. boosted its position in Synopsys by 0.5% during the fourth quarter. Williams Jones Wealth Management LLC. now owns 4,650 shares of the semiconductor company's stock valued at $2,257,000 after buying an additional 22 shares during the period. Hardy Reed LLC raised its position in Synopsys by 0.7% during the 1st quarter. Hardy Reed LLC now owns 3,290 shares of the semiconductor company's stock valued at $1,411,000 after purchasing an additional 22 shares during the last quarter. Resurgent Financial Advisors LLC raised its position in Synopsys by 2.7% during the 1st quarter. Resurgent Financial Advisors LLC now owns 832 shares of the semiconductor company's stock valued at $357,000 after purchasing an additional 22 shares during the last quarter. Trust Asset Management LLC raised its stake in Synopsys by 1.3% in the first quarter. Trust Asset Management LLC now owns 1,766 shares of the semiconductor company's stock worth $757,000 after buying an additional 22 shares in the last quarter. Finally, Argent Trust Co raised its stake in Synopsys by 2.8% in the first quarter. Argent Trust Co now owns 856 shares of the semiconductor company's stock worth $367,000 after buying an additional 23 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities analysts recently issued reports on SNPS shares. Rosenblatt Securities increased their price target on shares of Synopsys from $625.00 to $650.00 and gave the stock a "buy" rating in a research note on Friday, July 25th. Needham & Company LLC reissued a "buy" rating and issued a $660.00 price target (up from $650.00) on shares of Synopsys in a research note on Tuesday, July 15th. Wells Fargo & Company reissued a "positive" rating on shares of Synopsys in a research note on Wednesday, August 27th. KeyCorp increased their price target on shares of Synopsys from $610.00 to $660.00 and gave the stock an "overweight" rating in a research note on Wednesday. Finally, Piper Sandler increased their price target on shares of Synopsys from $615.00 to $660.00 and gave the stock an "overweight" rating in a research note on Monday, July 21st. Twelve research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, Synopsys has a consensus rating of "Moderate Buy" and an average price target of $638.21.
Get Our Latest Report on SNPS
Insider Buying and Selling at Synopsys
In other news, CRO Richard S. Mahoney sold 9,010 shares of Synopsys stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the transaction, the executive owned 1,485 shares in the company, valued at $699,746.85. This trade represents a 85.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the transaction, the chief executive officer owned 71,615 shares in the company, valued at $42,181,951.15. This represents a 13.70% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.62% of the company's stock.
Synopsys Stock Performance
Shares of Synopsys stock traded down $3.82 on Friday, hitting $598.14. 1,388,613 shares of the company's stock were exchanged, compared to its average volume of 973,467. The company has a 50-day simple moving average of $594.11 and a 200-day simple moving average of $506.12. The stock has a market capitalization of $92.81 billion, a PE ratio of 43.19, a PEG ratio of 3.93 and a beta of 1.14. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02.
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.